220 related articles for article (PubMed ID: 31671773)
21. Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response.
Pinoli P; Srihari S; Wong L; Ceri S
BMC Bioinformatics; 2021 May; 22(1):250. PubMed ID: 33992077
[TBL] [Abstract][Full Text] [Related]
22. Computational Prediction of Chemical Tools for Identification and Validation of Synthetic Lethal Interaction Networks.
Bhanumathy KK; Abuhussein O; Vizeacoumar FS; Freywald A; Vizeacoumar FJ; Phenix CP; Price EW; Cao R
Methods Mol Biol; 2021; 2381():333-358. PubMed ID: 34590285
[TBL] [Abstract][Full Text] [Related]
23. SL-Cloud: A Cloud-based resource to support synthetic lethal interaction discovery.
Tercan B; Qin G; Kim TK; Aguilar B; Phan J; Longabaugh W; Pot D; Kemp CJ; Chambwe N; Shmulevich I
F1000Res; 2022; 11():493. PubMed ID: 36761837
[TBL] [Abstract][Full Text] [Related]
24. Computational Prediction of Synthetic Lethals in Genome-Scale Metabolic Models Using Fast-SL.
Raman K; Pratapa A; Mohite O; Balachandran S
Methods Mol Biol; 2018; 1716():315-336. PubMed ID: 29222760
[TBL] [Abstract][Full Text] [Related]
25. Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.
Carbajosa S; Pansa MF; Paviolo NS; Castellaro AM; Andino DL; Nigra AD; García IA; Racca AC; Rodriguez-Berdini L; Angiolini V; Guantay L; Villafañez F; Federico MB; Rodríguez-Baili MC; Caputto BL; Drewes G; Madauss KP; Gloger I; Fernandez E; Gil GA; Bocco JL; Gottifredi V; Soria G
Clin Cancer Res; 2019 Jul; 25(13):4049-4062. PubMed ID: 30890549
[TBL] [Abstract][Full Text] [Related]
26. Synthetic lethality on drug discovery: an update on cancer therapy.
Yar MS; Haider K; Gohel V; Siddiqui NA; Kamal A
Expert Opin Drug Discov; 2020 Jul; 15(7):823-832. PubMed ID: 32228106
[TBL] [Abstract][Full Text] [Related]
27. Harnessing Synthetic Lethal Interactions for Personalized Medicine.
Shieh GS
J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055413
[TBL] [Abstract][Full Text] [Related]
28. TP53 mutations, expression and interaction networks in human cancers.
Wang X; Sun Q
Oncotarget; 2017 Jan; 8(1):624-643. PubMed ID: 27880943
[TBL] [Abstract][Full Text] [Related]
29. Overcoming selection bias in synthetic lethality prediction.
Seale C; Tepeli Y; Gonçalves JP
Bioinformatics; 2022 Sep; 38(18):4360-4368. PubMed ID: 35876858
[TBL] [Abstract][Full Text] [Related]
30. A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism.
Apaolaza I; San José-Enériz E; Valcarcel LV; Agirre X; Prosper F; Planes FJ
PLoS Comput Biol; 2022 Mar; 18(3):e1009395. PubMed ID: 35286311
[TBL] [Abstract][Full Text] [Related]
31. [Synthetic lethality as a functional tool in basic research and in anticancer therapy].
Toma M; Skorski T; Sliwiński T
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1091-103. PubMed ID: 25228518
[TBL] [Abstract][Full Text] [Related]
32. Embracing synthetic lethality of novel anticancer therapies.
Kamal A; Shaik TB; Malik MS
Expert Opin Drug Discov; 2015 Oct; 10(10):1119-32. PubMed ID: 26211783
[TBL] [Abstract][Full Text] [Related]
33. Harnessing DNA Double-Strand Break Repair for Cancer Treatment.
Trenner A; Sartori AA
Front Oncol; 2019; 9():1388. PubMed ID: 31921645
[TBL] [Abstract][Full Text] [Related]
34. Using graph-based model to identify cell specific synthetic lethal effects.
Pu M; Cheng K; Li X; Xin Y; Wei L; Jin S; Zheng W; Peng G; Tang Q; Zhou J; Zhang Y
Comput Struct Biotechnol J; 2023; 21():5099-5110. PubMed ID: 37920819
[TBL] [Abstract][Full Text] [Related]
35. SL-Miner: a web server for mining evidence and prioritization of cancer-specific synthetic lethality.
Liu X; Hu J; Zheng J
Bioinformatics; 2024 Feb; 40(2):. PubMed ID: 38244572
[TBL] [Abstract][Full Text] [Related]
36. Fast-SL: an efficient algorithm to identify synthetic lethal sets in metabolic networks.
Pratapa A; Balachandran S; Raman K
Bioinformatics; 2015 Oct; 31(20):3299-305. PubMed ID: 26085504
[TBL] [Abstract][Full Text] [Related]
37. Identification of synthetic lethality based on a functional network by using machine learning algorithms.
Li J; Lu L; Zhang YH; Liu M; Chen L; Huang T; Cai YD
J Cell Biochem; 2019 Jan; 120(1):405-416. PubMed ID: 30125975
[TBL] [Abstract][Full Text] [Related]
38. The tumor therapy landscape of synthetic lethality.
Zhang B; Tang C; Yao Y; Chen X; Zhou C; Wei Z; Xing F; Chen L; Cai X; Zhang Z; Sun S; Liu Q
Nat Commun; 2021 Feb; 12(1):1275. PubMed ID: 33627666
[TBL] [Abstract][Full Text] [Related]
39. DNA Double Strand Break Repair - Related Synthetic Lethality.
Toma M; Skorski T; Sliwinski T
Curr Med Chem; 2019; 26(8):1446-1482. PubMed ID: 29421999
[TBL] [Abstract][Full Text] [Related]
40. A landscape of synthetic viable interactions in cancer.
Gu Y; Wang R; Han Y; Zhou W; Zhao Z; Chen T; Zhang Y; Peng F; Liang H; Qi L; Zhao W; Yang D; Guo Z
Brief Bioinform; 2018 Jul; 19(4):644-655. PubMed ID: 28096076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
